Day One Biopharmaceuticals Inc (DAWN) — Cash Flow Quality Index

Latest as of September 2024: 1.37x

Day One Biopharmaceuticals Inc (DAWN) has a Cash Flow Quality Index of 1.37x as of September 2024. Operating cash flow of $50.75 Million exceeds net income of $37.04 Million, indicating high earnings quality where cash backs reported profits. Explore cash flow to debt ratio of Day One Biopharmaceuticals Inc to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

1.37x

Operating CF / Net Income

Operating Cash Flow

$50.75 Million

USD

Net Income

$37.04 Million

USD

Data as of

Sep 2024

Most recent filing

Annual Cash Flow Quality Index for Day One Biopharmaceuticals Inc (None–None)

Year-by-year earnings quality comparison for Day One Biopharmaceuticals Inc.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.